Stocks › DNLI

Denali Therapeutics DNLI

US equityMarket cap rank #2435Biotechnology

$19.91 −$0.09 (-0.45%)

Pre-market · Oct 6, 8:20 am ET · After hours $19.91 0.00%

Open$20.09

Prev close$20.00

Day range$19.54 – $20.09

Volume1.72M

Market cap$3.18B

P/E (TTM)–

Dividend yield–

Founded2013

CEODr. Ryan J. Watts, PhD

Employees503

HeadquartersSan Francisco, United States of America

Websitewww.denalitherapeutics.com

Biotechnology

Discussion

No comments yet — be the first to weigh in on DNLI.

Similar market cap

Stock	Price	Day	P/E
DNLI	$19.91	▼ 0.5%	–
OUST	$44.12	▼ 0.6%	–
USLM	$110.78	▼ 0.2%	23.7
CPK	$126.27	▼ 0.9%	21.2
ARLP	$24.79	▲ 1.1%	10.3
KEN	$61.21	▲ 1.2%	48.2
POST	$72.68	▲ 0.2%	13.2
LBRT	$19.59	▲ 1.5%	22.0
PLNT	$42.07	▼ 0.8%	16.1